Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2012
02/09/2012US20120034269 Analogs of alpha galactosylceramide and uses thereof
02/09/2012US20120034268 Bacterial ghosts for mediating innate immunity
02/09/2012US20120034267 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
02/09/2012US20120034266 Methods and compositions for improving immune response by a nutraceutical antioxidant
02/09/2012US20120034265 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034264 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034263 Sequences diagnostic for shrimp pathogens
02/09/2012US20120034262 Bovine Herpes Virus-1 Compositions, Vaccines and Methods
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034259 Antigen delivery vectors and constructs
02/09/2012US20120034258 Polypeptides and immunizing compounds containing gram positive polypeptides and methods of use
02/09/2012US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
02/09/2012US20120034256 Hcv vaccines and methods for using the same
02/09/2012US20120034255 Conformationally stabilized hiv envelope immunogens
02/09/2012US20120034254 Antigenic cloaking and its use
02/09/2012US20120034253 Influenza Vaccines, Antigens, Compositions, and Methods
02/09/2012US20120034252 Compositions and methods for inducing an immune response
02/09/2012US20120034248 Novel agonists of toll-like receptor 3 and methods of their use
02/09/2012US20120034247 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034246 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034244 Methods of treating secondary bone tumors with antibodies against pdgfr alpha
02/09/2012US20120034243 Method of Administering an Antibody
02/09/2012US20120034242 Cytokine-expressing cellular vaccine combinations
02/09/2012US20120034241 Immunogenic compositions and uses thereof
02/09/2012US20120034240 Perlecan as a biomarker for renal dysfunction
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034238 Compositions and methods for treating hepatitis virus infection
02/09/2012US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
02/09/2012US20120034236 Co-targeting of aurora a kinase and lim kinase 1 for cancer therapy
02/09/2012US20120034235 Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker
02/09/2012US20120034234 Methods for the treatment or prevention of systemic sclerosis
02/09/2012US20120034233 Methods of Treating an Overweight or Obese Subject
02/09/2012US20120034232 Tlr3 binding agents
02/09/2012US20120034231 Compositions and methods of use for therapeutic antibodies
02/09/2012US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA
02/09/2012US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
02/09/2012US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
02/09/2012US20120034227 Monoclonal antibody therapy for pancreas cancer
02/09/2012US20120034226 Diagnostic method of skin inflammatory disease
02/09/2012US20120034225 Suppressing Bone Loss with Anti-IL-19 Antibody
02/09/2012US20120034224 Treating Rheumatoid Arthritis with Anti-IL-19 Antibody
02/09/2012US20120034223 Methods of improving the therapeutic efficacy and utility of antibody fragments
02/09/2012US20120034222 Nitric Oxide Generating Medical Devices
02/09/2012US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof
02/09/2012US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof
02/09/2012US20120034219 Uses of il-23 agonists and antagonists; related reagents
02/09/2012US20120034218 RBM3 in Colorectal Cancer Prognostics
02/09/2012US20120034217 Anti-neoplastic compositions comprising extracts of black cohosh
02/09/2012US20120034216 Spiroketals
02/09/2012US20120034215 Anti-mst1r antibodies and uses thereof
02/09/2012US20120034214 Methods and kits for determining the prognosis of pulmonary sarcoidosis
02/09/2012US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
02/09/2012US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
02/09/2012US20120034211 EGFR antibodies comprising modular recognition domains
02/09/2012US20120034210 Compositions for potentiating apoposis signals in tumour cells
02/09/2012US20120034209 Treatment
02/09/2012US20120034208 Treating Breast Cancer with Anti-IL-19 Antibody
02/09/2012US20120034207 Production of her receptor antibodies in plant
02/09/2012US20120034206 Breast cancer eradication program
02/09/2012US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use
02/09/2012US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof
02/09/2012US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
02/09/2012US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012US20120034159 Antibodies that bind both bcma and taci
02/09/2012US20120034157 Artificial cells
02/09/2012US20120034156 Artificial cells
02/09/2012US20120034155 Artificial cells
02/09/2012CA2840993A1 Modified hepatitis c virus proteins
02/09/2012CA2815154A1 Use of her3 binding agents in prostate treatment
02/09/2012CA2807540A1 Medicinal agent and mode of prevention of hiv contamination, prevention and treatment of diseases caused by hiv and hiv-associated diseases including aids
02/09/2012CA2807529A1 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
02/09/2012CA2807523A1 Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein
02/09/2012CA2807514A1 Biomarkers for prostate cancer and methods for their detection
02/09/2012CA2807191A1 Glycolipid for treatment of ischemia reperfusion injury
02/09/2012CA2807141A1 Compositions and methods for inducing immune tolerance
02/09/2012CA2807127A1 Covalent diabodies and uses thereof
02/09/2012CA2807014A1 Dual variable domain immunoglobulins and uses thereof
02/09/2012CA2806855A1 Chronic lymphocytic leukemia (cll) biomarkers
02/09/2012CA2806454A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
02/09/2012CA2805685A1 Concentrated human immunoglobulin composition
02/09/2012CA2804967A1 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
02/08/2012EP2416155A1 Selecting sperm cells in a sperm cell population for use in an assited reproduction technique
02/08/2012EP2415783A1 Modified vaccinia virus strains for use in a diagnostic and therapeutic method
02/08/2012EP2415782A1 Compounds stimulating undesirable cellular adhesion and applications thereof
02/08/2012EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
02/08/2012EP2415483A1 Single dose use of cd20-specific binding molecules
02/08/2012EP2415482A2 Pharmaceutical compositions for treating metastasis
02/08/2012EP2415481A2 Immunostimulatory viral RNA oligonucleotides
02/08/2012EP2414546A2 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
02/08/2012EP2414399A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
02/08/2012EP2414398A2 Antibodies against human tweak and uses thereof
02/08/2012EP2414397A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
02/08/2012EP2414396A2 Preparation of isolated agonist anti-edar monoclonal antibodies
02/08/2012EP2414395A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
02/08/2012EP2414392A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
02/08/2012EP2414387A2 Compositions and methods related to protein a (spa) variants
02/08/2012EP2414385A2 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
02/08/2012EP2414383A1 C6orf167 peptides and vaccines containing the same
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 1823